Biotechnology

Filter

Current filters:

None

Popular Filters

1954 to 1978 of 2382 results

Australia's Greens want end to Big Pharma inducements

28-06-2012

Ahead of an announcement by pharma trade group Medicines Australia on a new Code of Conduct this week,…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

UK Phase I clinical trials insurance guidance published

27-06-2012

Three UK trade groups, the Association of the British Pharmaceutical Industry (ABPI), the BioIndustry…

BiotechnologyEuropeFinancialPharmaceuticalResearch

After recent R&D disappointments, pharma pipelines improving, says Thomson Reuters

27-06-2012

The pharmaceutical industry's research productivity is finally improving after years of disappointment,…

BiotechnologyMarkets & MarketingPharmaceuticalResearch

Australian patients to benefit from new PBS listings; OTC reforms

26-06-2012

The listing of 11 prescription medicines on the Australian Pharmaceutical Benefits Scheme (PBS) has been…

Asia-PacificBiotechnologyHealthcarePharmaceuticalPricingRegulation

Compugen and Merck Serono set up biomarker company Neviah Genomics

25-06-2012

German drug major Merck KGaA's (MRK: DE) Merck Serono division and Israel-based Compugen (Nasdaq: CGEN)…

BiotechnologyCompugenMerck KGaAMerck SeronoMergers & AcquisitionsResearch

Specialist funds launched to support novel regenerative therapies in UK

25-06-2012

Exclusive funding for regenerative medicine projects with academic and industry collaborators were launched…

BiotechnologyEuropeFinancialPharmaceuticalResearch

Sales of patented drug products in Canada flat due to lack of new high-volume blockbusters

25-06-2012

In 2011, sales of patented drug products in Canada increased toC$13.1 billion ($12.8 billion) from C$12.9…

BiotechnologyMarkets & MarketingNorth AmericaPharmaceuticalPricingResearch

Celgene slumps as it pulls new EU indication filing for Revlimid

22-06-2012

Celgene International, the European subsidiary of USA-based Celgene Corp (Nasdaq: CELG), has provided…

BiotechnologyCelgeneEuropeFinancialOncologyPharmaceuticalpomalidomideRegulationRevlimid

CSL Biotherapies indentifies likely reason for Fluvax problems

21-06-2012

Australia's largest biotech firm CSL Biotherapies, a division of CSL Limited (ASX: CSL) today presented…

Asia-PacificBiotechnologyCSL BiotherapiesCSL LimitedFluvaxMarkets & MarketingVaccines

ABPI takes stand against medicine's money wasting middle-men

21-06-2012

The role of brokers in the medicine transactional process has been denounced by Stephen Whitehead, chief…

BiotechnologyEuropeMarkets & MarketingPharmaceutical

Intellectual property encourages collaboration, R&D in developing economies

21-06-2012

The USA-based Biotechnology Industry Organization (BIO) unveiled a report on the role of intellectual…

BiotechnologyGlobalPatentsPharmaceuticalResearch

XTL Biopharma to acquire Kitov Pharmaceuticals

21-06-2012

Israeli biopharma firm XTL Biopharmaceuticals (TASE:XTL) says it will acquire fellow Israel-based Kitov…

BiotechnologyKitov PharmaceuticalsMergers & AcquisitionsPharmaceuticalXTL Biopharmaceuticals

Cell Therapeutics prepares for EU launch of Pixuvri

21-06-2012

USA-based biotech company Cell Therapeutics (Nasdaq and MTA: CTIC) said yesterday that it is re-aligning…

BiotechnologyCell TherapeuticsEuropeMarkets & MarketingOncologypacritinibPixuvriResearchtostedostat

Clinical trials market in Poland is growing, but at a moderate pace

20-06-2012

The clinical trials market in Poland will grow at a moderate pace, by around 5% per annum to 860 million…

BiotechnologyEuropeMarkets & MarketingPharmaceuticalResearch

US House and Senate reconcile PDUFA reauthorization legislation

20-06-2012

The US Congress has released a reconciled Prescription Drug User Fee Act (PDUFA) reauthorization bill…

BiotechnologyLegalNorth AmericaPharmaceuticalPoliticsRegulation

Tomorrow's BioPharma landscape viewed by EvaluatePharma

19-06-2012

The quantity of biologic drugs on the market will likely soar by 2018, according to analysts at Evaluate…

BiotechnologyFinancialGlobalMarkets & MarketingResearch

Issues to be navigated to unleash full potential of stem cell therapies

18-06-2012

Pharmaceutical, biotech and medical device companies are showing increased interest in stem cell research…

BiotechnologyPharmaceuticalPricingRegulationResearch

Quintiles expands operations in China

18-06-2012

US-headquartered biopharma services provider Quintiles yesterday announced agreements to establish a…

Asia-PacificBiotechnologyFinancialPharmaceuticalQuintilesResearch

Human Genome Sciences sets July 16 deadline for takeover bids

18-06-2012

In the latest update on UK pharma giant GlaxoSmithKline's (LSE: GSK) hostile takeover attempts for Human…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Second collaboration in Alzheimer's disease for Genentech and AC Immune

18-06-2012

Switzerland-based biopharma company AC Immune said this morning that it has entered into a second exclusive…

AC ImmuneBiotechnologycrenezumabGenentechLicensingNeurologicalPharmaceuticalResearchRoche

Ophthotech's Fovista tops Lucentis in wet AMD

15-06-2012

Privately-held US biotech firm Ophthotech Corp has announced results from the first clinical trial to…

BiotechnologyFovistaLucentisOphthalmicsOphthotechResearch

Osiris gets second approval for Prochymal, in New Zealand

15-06-2012

USA-based Osiris Therapeutics (Nasdaq: OSIR) has received a second approval to market its first-in-class…

Asia-PacificBiotechnologyImmunologicalsOsiris TherapeuticsProchymalRegulation

1954 to 1978 of 2382 results

Parexel

Parexel

Back to top